Impact of steatosis on perioperative outcome following hepatic resection Journal Article
| Authors: | Kooby, D. A.; Fong, Y.; Suriawinata, A.; Gonen, M.; Allen, P. J.; Klimstra, D. S.; DeMatteo, R. P.; D'Angelica, M.; Blumgart, L. H.; Jarnagin, W. R. |
| Article Title: | Impact of steatosis on perioperative outcome following hepatic resection |
| Abstract: | Fatty liver disease may interfere with liver regeneration and is postulated to result in an adverse outcome for patients subjected to partial hepatectomy. This study examines the impact of steatosis on outcome following hepatic resection for neoplasms. All patients with fatty livers (n=325) who underwent hepatectomy between December 1991 and September 2001 were identified from a prospective database. Slides were reviewed and steatosis was quantified as follows: <30% (mild) and ≥30% (marked). Patient data were gathered and compared with results in 160 control patients with normal livers; subjects were matched for age, comorbidity, and extent of liver resection. There were 223 patients with mild and 102 with marked steatosis. Those with steatosis were more likely to be men (59% marked vs. 55% mild vs. 43% control; P=0.01) with a higher body mass index (29.7±5.5 marked vs. 28.2±5.5 mild vs. 26.0±5.4 control; P<0.01), and treated preoperatively with chemotherapy (66% marked vs. 55% mild vs. 38% control; P<0.01). Total (62%, 48%, and 35%; P<0.01) and infective (43%, 24%, and 14%; P<0.01) complications correlated with the degree of steatosis. No difference was observed in complications requiring major medical intervention, hospitalization, or admission to the intensive care unit between groups. On multivariate analysis, steatosis was an independent predictor of complications (P<0.01, risk ratio=3.04, 95% confidence interval=1.7 to 5.54). There was a nonsignificant trend toward higher 60-day mortality in patients with marked steatosis who had lobe or more resections (9.4% marked vs. 5.0% mild vs. 5.0% control; P=0.30). Marked steatosis is an independent predictor of complications following hepatic resection but does not have a significant impact on 60-day mortality. Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution. © 2003 The Society for Surgery of the Alimentary Tract. |
| Keywords: | adult; cancer chemotherapy; controlled study; human tissue; treatment outcome; aged; middle aged; survival analysis; retrospective studies; major clinical study; mortality; postoperative period; liver neoplasms; conference paper; preoperative care; chemotherapy; antineoplastic agent; prospective study; infection; data base; prediction; risk assessment; postoperative complication; postoperative complications; confidence interval; intensive care unit; hospitalization; body mass; correlation analysis; disease severity; quantitative analysis; liver tumor; comorbidity; patient coding; predictive value of tests; liver resection; hepatectomy; hospital admission; multivariate analysis; sex difference; perioperative period; liver regeneration; fatty liver; steatosis; nonalcoholic steatohepatitis; surgical complications; humans; prognosis; human; male; female |
| Journal Title: | Journal of Gastrointestinal Surgery |
| Volume: | 7 |
| Issue: | 8 |
| ISSN: | 1091-255X |
| Publisher: | Springer |
| Date Published: | 2003-12-01 |
| Start Page: | 1034 |
| End Page: | 1043 |
| Language: | English |
| DOI: | 10.1016/j.gassur.2003.09.012 |
| PUBMED: | 14675713 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Presented at the 44th Annual Meeting of The Society for Surgery of the Alimentary Tract; 2003 May 17-22; Orlando, FL -- Export Date: 25 September 2014 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
352Blumgart -
637DeMatteo -
1028Gonen -
19Suriawinata -
25
Kooby -
978Klimstra -
501Allen -
903Jarnagin -
775Fong -
777D'Angelica
Related MSK Work